FDA is alerting doctors, patients, and caregivers about studies showing
that the "off-label" use of antipsychotic drugs to treat behavioral
disorders in elderly patients with dementia is associated with a higher
death rate when compared to patients receiving a placebo.

People Who experience mood swings, fear,
voices and visions: each other on the internet
www.peoplewho.org